NCT02889796 Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE3
NCT02886728 Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy Status COMPLETED Phase PHASE3
NCT02885818 Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02885181 Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate Status COMPLETED Phase PHASE2
NCT02884635 A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate Status COMPLETED Phase PHASE2
NCT02881307 Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet Status COMPLETED Phase NA
NCT02878161 Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World" Status UNKNOWN Phase PHASE4
NCT02876874 Relationship Between the Activity of Rheumatoid Arthritis and Lymph Node Morphology and Lymphatics Drainage Status UNKNOWN Phase N/A
NCT02873936 Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment Status COMPLETED Phase PHASE3
NCT02867306 A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT02862574 Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT02837146 Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis Status UNKNOWN Phase PHASE3
NCT02833350 Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT02831855 Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT02822521 A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis Flares Status COMPLETED Phase NA
NCT02820038 Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management Status COMPLETED Phase NA
NCT02819830 The Effects of a Six-week Exercise Programme Undertaken by Women With Rheumatoid Arthritis Status COMPLETED Phase NA